Effectiveness of Azelastine Nasal Solution in Seasonal Allergic Rhinitis
The DOI matches its Crossref record.
Abstract
Azelastine is a novel antiallergy medication currently under investigation for the treatment of allergic rhinitis and asthma. Pharmacologic studies in laboratory animals and in vitro model systems indicate that azelastine exerts multiple actions including modulation of airways smooth muscle response, interference with inflammatory processes, and inhibition of allergic reactions. In a previous controlled clinical trial, azelastine nasal solution (ASTELIN N.S.™) demonstrated effectiveness in controlling symptoms of seasonal allergic rhinitis (SAR). The objective of this 2-week double-blind, parallel-group study was to further assess the effectiveness of azelastine nasal solution in improving allergic rhinitis symptoms. Two hundred forty-seven patients (≥12 years) with symptomatic SAR who satisfied a minimum symptoms score during a 1-week, single-blind, baseline evaluation period were randomized to receive azelastine 2 sprays per nostril bid, azelastine 2 sprays per nostril qd, chlorpheniramine 12 mg bid, or placebo using a double-dummy technique to insure blinding. The primary efficacy variables were changes in Major Symptom Complex (nose blows, sneezes, runny nose/sniffles, itch nose, and watery eyes) and Total Symptom Complex (Major plus itchy eyes/ears/throat/palate, cough, and postnasal drip) severity scores. Patients treated with azelastine nasal solution qd and bid had mean percent improvements in the Total and Major Symptom Complex severity scores that were clinically significant (≥50% improvement over placebo) after both weeks, at endpoint, and overall. The improvements for the azelastine bid group were statistically significant (P≤.05) at all evaluation points. Adverse experiences occurred infrequently, and none was considered serious or potentially limiting to the clinical utility of the nasal solution. The favorable safety profile of azelastine nasal solution together with its rapid onset and prolonged duration of action in relieving rhinitis symptoms and advantages over currently marketed topical treatments make it a good choice for treatment of SAR. The results of this trial demonstrate that azelastine nasal solution provides an alternative to oral medication in the treatment of SAR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Allergic Rhinitis and Its Impact on Asthma
Bousquet, J., van Cauwenberge, P., & Khaltaev, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118891 · Cited by 3,588
Rhinitis 2020: A practice parameter update
Dykewicz, M. S., Wallace, D. V., Amrol, D. J., Baroody, F. M., Bernstein, J. A., Craig, T. J., Dinakar, C., Ellis, A. K., Finegold, I., Golden, D. B. K., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.07.007 · Cited by 436
Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis
Banov, C. H., & Lieberman, P. (2001) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)62352-6 · Cited by 135
Golden, S., Teets, S. J., Lehman, E. B., Mauger, E. A., Chinchilli, V., Berlin, J. M., Kakumanu, S., Lucus, T., & Craig, T. J. (2000) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)62434-9 · Cited by 46
Pearlman, D. S., Grossman, J., & Meltzer, E. O. (2003) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)63527-2 · Cited by 18
Self-citation
Metadata
- Authors
- Storms, W. W., Grossman, J., Pearlman, D. S., Halverson, P. C., Chervinsky, P., Freitag, J. J., & Widlitz, M. D.
- Venue
- Ear, Nose & Throat Journal
- Publisher
- SAGE Publications
- Published
- 1994-06
- Volume
- 73
- Issue
- 6
- Pages
- 382-394
- ISSN
- 0145-5613 (ISSN-L)
- 1942-7522
- OpenAlex
- W180119566
- Cited by
- 47
- References
- 0
- FWCI
- 0.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effectiveness of Azelastine Nasal Solution in Seasonal Allergic Rhinitis. https://app.cochat.ai/papers/10.1177/014556139407300608
- The paper
- Storms, W. W., Grossman, J., Pearlman, D. S., Halverson, P. C., Chervinsky, P., Freitag, J. J., & Widlitz, M. D. (1994). Effectiveness of Azelastine Nasal Solution in Seasonal Allergic Rhinitis. Ear, Nose & Throat Journal. https://doi.org/10.1177/014556139407300608
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.